Klf4 Inhibits Tumor Growth and Metastasis by Targeting MicroRNA-31 in Human Hepatocellular Carcinoma

Overview

Journal Int J Mol Med

Specialty Genetics

Date 2016 Dec 3

PMID 27909734

Citations 12

Authors

Chuan Tian

Shanshan Yao

Li Liu

Youcheng Ding

Qingwang Ye

Xiao Dong

Yong Gao

Ning Yang

Qi Li

Affiliations

Soon will be listed here.

Abstract

MicroRNAs (miRNAs or miRs) are short, endogenous non-coding RNA molecules, demonstrating abnormal expression in cancer initiation and progression. In this study, we profiled 18 differentially regulated miRNAs, including miRNA‑31, using miRNA array. Kruppel (or Krüppel)-like factor 4 (Klf4) is a transcription factor and putative tumor suppressor. Both were found to be significantly downregulated in liver cancer tissues and cells. However, little is known about the correlation between Klf4 and miRNA‑31 in hepatocellular carcinoma (HCC). The mRNA expression of Klf4 was decreased and inversely associated with the clinical stage, T classification and hepatitis B in patients with HCC, while the expression of miR‑31 was lower (r=0.326, P=0.018). Using cell counting kit 8 (CCK8) and Transwell migration assays, we found that Klf4 and miR‑31 inhibited the proliferation and metastasis of liver cancer cells. Moreover, we demonstrated that Klf4 directly binds to the promoter of miR‑31 and activates its transcription. In vitro experiments confirmed that Klf4 regulated miR‑31 and thereby inhibited HCC cell growth and metastasis. Taken together, our findings indicate that Klf4 directly regulates miR‑31 in HCC. Thus, miR-31 may serve as a potential diagnostic marker and therapeutic target in HCC.

Citing Articles

The spring-like effect of microRNA-31 in balancing inflammatory and regenerative responses in colitis.

Qu J, Shao C, Ying Y, Wu Y, Liu W, Tian Y Front Microbiol. 2023; 13:1089729.

PMID: 36590397 PMC: 9800619. DOI: 10.3389/fmicb.2022.1089729.

Role and clinical significance of TGF‑β1 and TGF‑βR1 in malignant tumors (Review).

Wang J, Xiang H, Lu Y, Wu T Int J Mol Med. 2021; 47(4).

PMID: 33604683 PMC: 7895515. DOI: 10.3892/ijmm.2021.4888.

Recent Discoveries on the Involvement of Krüppel-Like Factor 4 in the Most Common Cancer Types.

Taracha-Wisniewska A, Kotarba G, Dworkin S, Wilanowski T Int J Mol Sci. 2020; 21(22).

PMID: 33266506 PMC: 7700188. DOI: 10.3390/ijms21228843.

MicroRNA-7 Targets the KLF4 Gene to Regulate the Proliferation and Differentiation of Chicken Primary Myoblasts.

Zhang G, Chen F, Wu P, Li T, He M, Yin X Front Genet. 2020; 11:842.

PMID: 33193566 PMC: 7530283. DOI: 10.3389/fgene.2020.00842.

PEX5, a novel target of microRNA-31-5p, increases radioresistance in hepatocellular carcinoma by activating Wnt/β-catenin signaling and homologous recombination.

Wen J, Xiong K, Aili A, Wang H, Zhu Y, Yu Z Theranostics. 2020; 10(12):5322-5340.

PMID: 32373215 PMC: 7196300. DOI: 10.7150/thno.42371.

References

Wang S, Li Q, Wang K, Dai Y, Yang J, Xue S . Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer. Clin Transl Oncol. 2013; 15(10):849-54. DOI: 10.1007/s12094-013-1014-4. View

Maluccio M, Covey A . Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin. 2012; 62(6):394-9. DOI: 10.3322/caac.21161. View

Lin Z, Chu H, Yen Y, Lewis B, Chen Y . Krüppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression. PLoS One. 2012; 7(8):e43593. PMC: 3427336. DOI: 10.1371/journal.pone.0043593. View

Creighton C, Fountain M, Yu Z, Nagaraja A, Zhu H, Khan M . Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer Res. 2010; 70(5):1906-15. PMC: 2831102. DOI: 10.1158/0008-5472.CAN-09-3875. View

He X, Guo A, Xu C, Chang Y, Xiang G, Gong J . Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor properties. Oncol Rep. 2014; 32(3):1200-10. DOI: 10.3892/or.2014.3306. View

Vire E, Curtis C, Davalos V, Git A, Robson S, Villanueva A . The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31. Mol Cell. 2014; 53(5):806-18. PMC: 3988886. DOI: 10.1016/j.molcel.2014.01.029. View

Gao W, Liu L, Xu J, Shao Q, Liu Y, Zeng H . A systematic analysis of predicted MiR-31-targets identifies a diagnostic and prognostic signature for lung cancer. Biomed Pharmacother. 2014; 68(4):419-27. DOI: 10.1016/j.biopha.2014.03.009. View

Lu W, Liu C, Tu H, Chung Y, Yang C, Kao S . miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma. Oncotarget. 2016; 7(35):57254-57267. PMC: 5302987. DOI: 10.18632/oncotarget.11138. View

Fiorenza A, Lopez-Atalaya J, Rovira V, Scandaglia M, Geijo-Barrientos E, Barco A . Blocking miRNA Biogenesis in Adult Forebrain Neurons Enhances Seizure Susceptibility, Fear Memory, and Food Intake by Increasing Neuronal Responsiveness. Cereb Cortex. 2015; 26(4):1619-1633. DOI: 10.1093/cercor/bhu332. View

10.

Di Leva G, Garofalo M, Croce C . MicroRNAs in cancer. Annu Rev Pathol. 2013; 9:287-314. PMC: 4009396. DOI: 10.1146/annurev-pathol-012513-104715. View

11.

Yang F, Yin Y, Wang F, Wang Y, Zhang L, Tang Y . miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway. Hepatology. 2010; 51(5):1614-23. DOI: 10.1002/hep.23566. View

12.

Yu T, Chen X, Lin T, Liu J, Li M, Zhang W . KLF4 deletion alters gastric cell lineage and induces MUC2 expression. Cell Death Dis. 2016; 7(6):e2255. PMC: 5143387. DOI: 10.1038/cddis.2016.158. View

13.

Kim H, Lee K, Bae H, Eun J, Shen Q, Park S . MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer. Oncotarget. 2015; 6(10):8089-102. PMC: 4480737. DOI: 10.18632/oncotarget.3512. View

14.

Li Q, Gao Y, Jia Z, Mishra L, Guo K, Li Z . Dysregulated Krüppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma. Gastroenterology. 2012; 143(3):799-810.e2. PMC: 3653768. DOI: 10.1053/j.gastro.2012.05.043. View

15.

Taccioli C, Garofalo M, Chen H, Jiang Y, Tagliazucchi G, Di Leva G . Repression of Esophageal Neoplasia and Inflammatory Signaling by Anti-miR-31 Delivery In Vivo. J Natl Cancer Inst. 2015; 107(11). PMC: 4675101. DOI: 10.1093/jnci/djv220. View

16.

Moeini A, Cornella H, Villanueva A . Emerging signaling pathways in hepatocellular carcinoma. Liver Cancer. 2013; 1(2):83-93. PMC: 3747540. DOI: 10.1159/000342405. View

17.

Lv H, Zhang Z, Wang Y, Li C, Gong W, Wang X . MicroRNA-92a Promotes Colorectal Cancer Cell Growth and Migration by Inhibiting KLF4. Oncol Res. 2016; 23(6):283-90. PMC: 7838653. DOI: 10.3727/096504016X14562725373833. View

18.

Meehan K, Vella L . The contribution of tumour-derived exosomes to the hallmarks of cancer. Crit Rev Clin Lab Sci. 2015; 53(2):121-31. DOI: 10.3109/10408363.2015.1092496. View

19.

Zhou J, Bo-San Lai P, Tsui S . Identification of a non-coding KLF4 transcript generated from intron retention and downregulated in human hepatocellular carcinoma. Int J Oncol. 2015; 47(4):1554-62. DOI: 10.3892/ijo.2015.3104. View

20.

Najafi Z, Sharifi M, Javadi G . Degradation of miR-21 induces apoptosis and inhibits cell proliferation in human hepatocellular carcinoma. Cancer Gene Ther. 2015; 22(11):530-5. DOI: 10.1038/cgt.2015.51. View